Human milk composition differs in healthy mothers and mothers with celiac disease

Eur J Nutr. 2015 Feb;54(1):119-28. doi: 10.1007/s00394-014-0692-1. Epub 2014 Apr 4.

Abstract

Purpose: To investigate whether breast-milk composition and microbiota differ in healthy mothers and mothers with celiac disease (CD) to ultimately contribute to identify additional factors determining CD risk.

Methods: Breast-milk samples from healthy mothers (n = 12) and mothers with CD (n = 12) were collected. Cytokines and secretory immunoglobulin A (sIgA) were analyzed by bead-arrays and flow cytometry and human milk oligosaccharides (HMOs) were assessed by capillary electrophoresis with laser-induced fluorescence (CE-LIF) detection. Breast-milk microbiota composition was analyzed by conventional and quantitative real-time PCR.

Result: Breast milk from CD mothers showed significantly lower levels of interleukin (IL) 12p70 (P < 0.042), transforming growth factor (TGF)-β1 (P < 0.018) and sIgA (P < 0.003) and almost significantly lower levels of interferon (IFN)-γ (P < 0.058). Six mothers in each group belonged to the secretor Le(a-b+) type, one to the secretor Le(a-b-) type and five to the non-secretor Le(a+b-) type. CD mothers of non-secretor Le(a+b-) type showed increased Lacto-N-tetraose content (P < 0.042) compared with healthy mothers. CD mothers' milk showed reduced gene copy numbers of Bifidobacterium spp. (P < 0.026) and B. fragilis group (P < 0.044).

Conclusion: CD mothers' breast milk is characterized by a reduced abundance of immunoprotective compounds (TGF-β1 and sIgA) and bifidobacteria. The reduction in these components could theoretically diminish the protective effects of breast-feeding on the child's future risk of developing CD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bacteroides fragilis / classification
  • Bacteroides fragilis / genetics
  • Bacteroides fragilis / growth & development
  • Bacteroides fragilis / isolation & purification*
  • Bifidobacterium / classification
  • Bifidobacterium / genetics
  • Bifidobacterium / growth & development
  • Bifidobacterium / isolation & purification*
  • Case-Control Studies
  • Celiac Disease / diet therapy
  • Celiac Disease / immunology
  • Celiac Disease / metabolism*
  • Celiac Disease / microbiology
  • Cytokines / analysis*
  • Cytokines / metabolism
  • Diet, Gluten-Free
  • Family Health
  • Female
  • Gene Dosage
  • Genes, Bacterial
  • Humans
  • Immunoglobulin A, Secretory / analysis*
  • Immunoglobulin A, Secretory / metabolism
  • Interferon-gamma / analysis
  • Interferon-gamma / metabolism
  • Interleukin-12 / analysis
  • Interleukin-12 / metabolism
  • Lewis Blood Group Antigens / metabolism
  • Maternal Nutritional Physiological Phenomena
  • Milk, Human / chemistry*
  • Milk, Human / microbiology
  • Molecular Typing
  • Oligosaccharides / analysis*
  • Oligosaccharides / metabolism
  • Transforming Growth Factor beta1 / analysis
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Cytokines
  • IFNG protein, human
  • Immunoglobulin A, Secretory
  • Lewis Blood Group Antigens
  • Oligosaccharides
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Interleukin-12
  • Interferon-gamma
  • lacto-N-neotetraose